For the quarter ending 2026-03-31, LNZA had $6,715K increase in cash & cash equivalents over the period. -$9,323K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Consolidated revenues | 12,020 | 27,999 | 9,279 | - |
| Consolidated cost of sales | 8,291 | 9,885 | 6,916 | - |
| Salaries and benefits expenses | 9,299 | 9,377 | 11,833 | - |
| External service providers | 3,549 | 2,365 | 2,473 | - |
| Other operating expenses (net of recharges) | 692 | 6,577 | 3,714 | - |
| Loss from operations | -9,811 | -205 | -15,657 | - |
| Other income (expense), net | -319 | 2,650 | 18,670 | - |
| Loss from equity method investees, net | -4,549 | -2,529 | -152 | - |
| Net loss | -14,679 | -84 | 2,861 | -51,728 |
| Share-based compensation expense | 1,327 | 1,288 | 1,357 | 4,556 |
| Gain on change in fair value of safe and warrant liabilities | -4 | -32 | -253 | -3,184 |
| Loss on change in fair value of the amended brookfield loan | -100 | 0 | 7,135 | -12,445 |
| Gain on change in fair value of the amended brookfield loan | - | 2,400 | -1,000 | - |
| Loss on brookfield safe extinguishment | 0 | 0 | 0 | -6,216 |
| Loss on change in fair value of the fpa put option and the fixed maturity consideration liabilities | - | - | - | 0 |
| Loss on change in fair value of the fpa put option and current fpa put option liability | - | - | 0 | - |
| Loss on change in fair value of the fpa put option and the fixed maturity consideration liabilities | - | 0 | - | - |
| Change in fair value of convertible note | 0 | 0 | 0 | 42,980 |
| Gain on change in fair value of pipe warrant liability | - | 0 | -12,200 | 3,400 |
| Gain on partial lease termination | - | 0 | 0 | 60 |
| Provisions for losses on trade and other receivables and contract assets, net of recoveries | 0 | 1,868 | 0 | 126 |
| Depreciation of property, plant and equipment | 939 | 1,367 | 1,025 | 1,835 |
| Amortization of discount on debt security investment | 0 | 0 | 0 | 34 |
| Non-cash lease expense | 262 | 170 | 466 | 917 |
| Non-cash recognition of licensing revenue | 498 | 17,052 | 1,399 | 2,214 |
| Loss from equity method investees, net | -4,549 | -2,529 | -152 | -9,867 |
| Loss from disposal of property, plant and equipment | - | 0 | - | - |
| Unrealized (gain)/loss on net foreign exchange | 244 | -64 | 103 | -649 |
| Accounts receivable, net | 1,030 | 830 | 1,621 | -2,334 |
| Contract assets | 221 | -927 | 1,361 | -11,231 |
| Accrued interest on debt investment | 0 | 0 | 0 | 83 |
| Other assets | 394 | -2,519 | -2,354 | -1,377 |
| Accounts payable and accrued salaries and wages | -558 | 4,584 | 1,419 | -882 |
| Contract liabilities | 317 | -271 | -165 | 61 |
| Operating lease liabilities | -237 | -638 | -114 | -877 |
| Other liabilities | 1,103 | -171 | -2,160 | 4,213 |
| Net cash used in operating activities | -9,268 | -6,162 | -15,877 | -42,815 |
| Purchase of property, plant and equipment | 55 | 211 | 168 | 879 |
| Proceeds from disposal of property, plant and equipment | 42 | 0 | - | - |
| Purchase of debt securities | - | 0 | 0 | - |
| Purchase of additional lanzajet equity method investment | 2,000 | - | - | - |
| Proceeds from maturity of debt securities | 0 | 0 | 0 | 12,408 |
| Proceeds from pipe warrant | - | 0 | 0 | 24,950 |
| Net cash (used in) provided by investing activities | -2,013 | -211 | -168 | 11,529 |
| Proceeds from exercise of options | - | 0 | - | - |
| Proceeds from issuance of preferred stock | - | 0 | 0 | 15,050 |
| Proceeds from issuance of convertible note, net | - | 0 | 0 | - |
| Repurchase of equity instruments of the company | - | 0 | 0 | 0 |
| Proceeds from issue of equity instruments of the company | - | - | 0 | 0 |
| Issuance costs related to preferred stock | - | 0 | 0 | 1,881 |
| Proceeds from issuance of common stock | 20,000 | - | - | - |
| Settlement of forward purchase agreement | 2,000 | 0 | - | - |
| Partial settlement of the brookfield loan | 0 | 0 | 0 | 12,500 |
| Net cash provided by (used in) financing activities | 18,000 | 0 | 0 | 25,619 |
| Effects of currency translation on cash, cash equivalents and restricted cash | -4 | -78 | -98 | -425 |
| Net decrease in cash, cash equivalents and restricted cash | 6,715 | -6,451 | -16,143 | -6,092 |
| Cash, cash equivalents and restricted cash at beginning of period | 17,051 | 23,502 | 45,737 | - |
| Cash, cash equivalents and restricted cash at end of period | 23,766 | 17,051 | 23,502 | - |
LanzaTech Global, Inc. (LNZA)
LanzaTech Global, Inc. (LNZA)